CN1145789A - Non-toxic sedative anticancer Chinese medicine capsule - Google Patents
Non-toxic sedative anticancer Chinese medicine capsule Download PDFInfo
- Publication number
- CN1145789A CN1145789A CN95112013A CN95112013A CN1145789A CN 1145789 A CN1145789 A CN 1145789A CN 95112013 A CN95112013 A CN 95112013A CN 95112013 A CN95112013 A CN 95112013A CN 1145789 A CN1145789 A CN 1145789A
- Authority
- CN
- China
- Prior art keywords
- gram
- radix
- toxic
- sedative
- anticancer chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to anticancer medicine and aims at overcoming the demerits of available similar medicines. The medicine consists of 15 kinds of Chinese medicinal material including Cordyceps sinensis, glossy ganoderma, rabdosia rubescens, ginseng, pangolin scales, etc. It can cure various malignant tumors and raise the immunity of body.
Description
The present invention relates to a kind of Chinese patent medicine, particularly relate to a kind of human body immunity improving power, prolong the non-toxic sedative anticancer medicine of antibody life period.
At present, relate to that the Chinese patent medicine for the treatment of cancer has with Radix Trichosanthis, Radix Clematidis, Rhizoma Curcumae, Scolopendra, Venenum Bufonis is the FUFANG TIANXIAN JIAONANG that principal agent is made; With Radix Sophorae Flavescentis, BANJILIAN is ginseng lotus capsule of making of principal agent or the like, the Chinese patent medicine of these treating cancers, and its treatment tumor spectrum and antimicrobial spectrum are narrower, and especially analgesic effect is poor, and the speed of producing effects is slow, and side effect usually takes place.
The objective of the invention is the weak point of controlling the cancer Chinese patent medicine at existing, compose and the antimicrobial spectrum broad and disclose a kind of treatment tumor, nontoxic, pain relieving, the fast cancer Chinese patent medicine of controlling produces effects.
The objective of the invention is to be achieved through the following technical solutions: promptly with Cordyceps, natural glossy ganoderma, Armadillidium, Rabdosia rubescens and Herba Pileae Scriptae are drug of first choice, is furnished with Radix Ginseng simultaneously, Squama Manis, Carapax Trionycis (processed), Radix Gossypii, Aloe, Flos Lonicerae, Radix Notoginseng, Semen Hyoscyami, Plantula Papaveris and Flos Chrysanthemi, its every batch dose is respectively according to said sequence: the 38-55 gram, the 22-38 gram, the 45-58 gram, the 15-25 gram, the 13-27 gram, the 25-37 gram, the 26-38 gram, the 14-26 gram, the 33-50 gram, the 25-36 gram, the 10-20 gram, the 16-25 gram, the 6-15 gram, the 15-25 gram, the 24-40 gram, more than many Chinese medicine, all oven dry is ground into 90-180 order microgranule, remix is gone into capsule, and this medicine bag substance is the 0.3-0.5 gram.
The non-toxic sedative anticancer Chinese medicinal capsule of above-mentioned compatibility has strengthening vital QI to eliminate pathogenic factors, spasmolysis and analgesia, hard masses softening and resolving, heat-clearing and toxic substances removing, removing food stagnancy reduces phlegm, blood circulation promoting and blood stasis dispelling, inducing diuresis to remove edema, relieving convulsion hemostasis, enriching yin and nourishing kidney, the yin nourishing of promoting the production of body fluid, anti-inflammation, with anticancer dispersing tumor effect, thereby realized antitumor, defying age, antiallergic, antiviral, the goal of the invention of enhancing human body immunity power.
A kind of non-toxic sedative anticancer Chinese medicinal capsule of the present invention has following advantage compared to existing technology:
1, owing to contains Rabdosia rubescens, Herba Pileae Scriptae, Squama Manis, Cordyceps in this medicine, Carapax Trionycis (processed), and Radix Ginseng, system such as in therefore can enhancing body netted, activate the specific immunity cell, the cancer inhibitting and killing cell improves antibody mediated immunity power and prolongs the antibody life period thereby reach.
2, owing to contain Aloe in this medicine, therefore strengthen the vigor of NK cell (natural killer cell and natural killer cell) in the human body greatly.
3, owing to contain Ganoderma in this medicine, the ganoderan effect is strengthened, human body is obvious leukocyte increasing number, haemachrome, and platelet promotes regeneration of erythrocytes and immunoglobulin LGA to raise.
4, owing to contain polynary medical material in this medicine, therefore have several amino acids and various trace elements.
5, because this medicine has adopted strengthening vital QI to eliminate pathogenic factors, vital base and primordial QI consolidating is changed the apolegamy medicine maneuver of tumor eliminating stagnation, thereby has overcome the side effect that is produced with the malicious merit poison practice.
Claims (3)
1, a kind of non-toxic sedative anticancer Chinese medicinal capsule is characterized in that with Cordyceps, natural glossy ganoderma, and Armadillidium, Rabdosia rubescens and Herba Pileae Scriptae are principal agent, are furnished with simultaneously: Radix Ginseng, Squama Manis, Carapax Trionycis (processed), Radix Gossypii, Aloe, Flos Lonicerae, Radix Notoginseng, Semen Hyoscyami, Plantula Papaveris and Flos Chrysanthemi.
2, a kind of non-toxic sedative anticancer Chinese medicine glue Nang according to claim 1, it is characterized in that said Cordyceps, natural glossy ganoderma, Armadillidium, Rabdosia rubescens, Herba Pileae Scriptae, Radix Ginseng, Squama Manis, Carapax Trionycis (processed), Radix Gossypii, Aloe, Flos Lonicerae, Radix Notoginseng, Semen Hyoscyami, Plantula Papaveris and Flos Chrysanthemi, going into dose for its every batch is respectively according to said sequence: 38-55 gram, 22-38 gram, 45-58 gram, 15-25 gram, 23-27 gram, 25-37 gram, 26-38 gram, 14-26 gram, 33-50 gram, 25-36 gram, 10-20 gram, 16-25 gram, the 6-15 gram, the 15-25 gram, the 24-40 gram.
3,, it is characterized in that said principal agent and compatibility drug are all dried to be ground into microgranule that its granularity is the 90-180 order according to claim 1,2 described non-toxic sedative anticancer Chinese medicinal capsules.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95112013A CN1060064C (en) | 1995-09-22 | 1995-09-22 | Non-toxic sedative anticancer Chinese medicine capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95112013A CN1060064C (en) | 1995-09-22 | 1995-09-22 | Non-toxic sedative anticancer Chinese medicine capsule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1145789A true CN1145789A (en) | 1997-03-26 |
| CN1060064C CN1060064C (en) | 2001-01-03 |
Family
ID=5079239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN95112013A Expired - Fee Related CN1060064C (en) | 1995-09-22 | 1995-09-22 | Non-toxic sedative anticancer Chinese medicine capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1060064C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1073855C (en) * | 1999-07-09 | 2001-10-31 | 秦思承 | Aloe composition |
| CN1879761B (en) * | 2005-06-13 | 2012-02-01 | 孙尚见 | A health product for regulating immunity and resisting mutation and method for preparing same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1077122A (en) * | 1992-04-11 | 1993-10-13 | 张士舜 | A kind of compound anticancer capsule preparation |
| CN1100936A (en) * | 1993-09-30 | 1995-04-05 | 李健三 | Life-prolonging and anti-tumor preparation of Chinese traditional medicine and preparation method |
| CN1102576A (en) * | 1993-11-08 | 1995-05-17 | 李延春 | Anti-cancer paste and its prepn. |
| CN1099993A (en) * | 1994-04-08 | 1995-03-15 | 蓝烈风 | Biological immunopotentiator "Kangaiping" |
| CN1054289C (en) * | 1994-07-01 | 2000-07-12 | 柳毅 | Medicine for curing tumour |
-
1995
- 1995-09-22 CN CN95112013A patent/CN1060064C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1073855C (en) * | 1999-07-09 | 2001-10-31 | 秦思承 | Aloe composition |
| CN1879761B (en) * | 2005-06-13 | 2012-02-01 | 孙尚见 | A health product for regulating immunity and resisting mutation and method for preparing same |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1060064C (en) | 2001-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1062474C (en) | Glossy ganoderma-Eighteen treasure oral liquid | |
| CN1055638C (en) | Selenium-riched Chinese caterpillar fungus oral liquor and its prepn. method | |
| CN1060064C (en) | Non-toxic sedative anticancer Chinese medicine capsule | |
| CN110934924A (en) | Traditional Chinese medicine bone marrow hematogenesis composition and application thereof | |
| CN1073861C (en) | External use medicinal bag for treating acute and chronic gastritis and cholecystitis, and preparing method thereof | |
| CN1058165C (en) | Chinese drugs for curing hepatitis B | |
| CN1242806C (en) | Medicine | |
| CN1164318C (en) | Capsule for treating gynaecological inflammation | |
| CN1085439A (en) | A kind of anticancer herbal drug | |
| CN1061249C (en) | Quick-acting traditional Chinese medicine for curing hepatitis B | |
| CN1055228C (en) | Medicine for treating chronic bronchitis and preparation method thereof | |
| CN1092055C (en) | Chinese medicine preparation | |
| CN1186060C (en) | Chinese medicine capsule and adhesive plaster for treating mammary cancer and its preparation method | |
| CN1199632A (en) | Chinese medicine preparation as adjuvant for chemotherapy of tumour and its preparation process | |
| CN1061887C (en) | Shengxuebao-medicine for improving hematopoitic function | |
| CN1320453A (en) | Capsule for treating headache and heimcrania | |
| CN1031781C (en) | Making method of strong thrombus-dissolving capsule | |
| CN1070707C (en) | Traditional Chinese medicine for curing AIDS and its producing method | |
| CN1196263A (en) | Chinese medicinal preparation for treating leukemia | |
| CN1063076C (en) | Traditional Chinese medicinal leukogenic prepn. | |
| CN1105584A (en) | Chinese herbal medicine for curing osteomyelitis-like bone tumor | |
| CN1066045C (en) | Blood nourishing granules | |
| CN1163239C (en) | Medicine for treating gynopathy | |
| CN1219405A (en) | Aifukang capsule for curing cancer | |
| CN1048407C (en) | Tongqiaohuasheng pills |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Zhou Wende Document name: payment instructions |
|
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |